Association of interleukin 1 receptor antagonist intron 2 variable number of tandem repeats polymorphism with vitiligo susceptibility in Gujarat population

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Indian Journal of Dermatology, Venereology and Leprology

• Publication date

  2018-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4103/ijdvl.IJDVL_1_17PMID 29620037
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat

  2017cited by this paper
• The catalase gene promoter and 5ʹ‐untranslated region variants lead to altered gene expression and enzyme activity in vitiligo

  2017cited by this paper
• Interleukin 1-α: A Modulator of Melanocyte Homeostasis in Vitiligo

  2016cited by this paper
• Genetic variations (Arg5Pro and Leu6Pro) modulate the structure and activity of GPX1 and genetic risk for vitiligo

  2016cited by this paper
• miRNA signatures and transcriptional regulation of their target genes in vitiligo.

  2016cited by this paper
• Role of oxidative stress and autoimmunity in onset and progression of vitiligo

  2014cited by this paper
• IFN-γ signaling maintains skin pigmentation homeostasis through regulation of melanosome maturation

  2014cited by this paper
• Polymorphisms in TSHR and IL1RN genes and the risk and prognosis of Hashimoto’s thyroiditis

  2014cited by this paper
• Association of Neuropeptide Y (NPY), Interleukin-1B (IL1B) Genetic Variants and Correlation of IL1B Transcript Levels with Vitiligo Susceptibility

  2014cited by this paper
• Could ER Stress Be A Major Link Between Oxidative Stress And Autoimmunity In Vitiligo

  2014cited by this paper
• In vitro effect of immune regulatory cytokines on vitiligo pathogenesis

  2014cited by this paper
• Correlation of increased MYG1 expression and its promoter polymorphism with disease progression and higher susceptibility in vitiligo patients.

  2013cited by this paper
• Involvement of Interferon-Gamma Genetic Variants and Intercellular Adhesion Molecule-1 in Onset and Progression of Generalized Vitiligo

  2013cited by this paper
• Tumor Necrosis Factor B (TNFB) Genetic Variants and Its Increased Expression Are Associated with Vitiligo Susceptibility

  2013cited by this paper
• Involvement of superoxide dismutase isoenzymes and their genetic variants in progression of and higher susceptibility to vitiligo.

  2013cited by this paper
• Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population

  2013cited by this paper
• Vitiligo: interplay between oxidative stress and immune system

  2013cited by this paper
• Increased Tumor Necrosis Factor (TNF)-α and Its Promoter Polymorphisms Correlate with Disease Progression and Higher Susceptibility towards Vitiligo

  2012cited by this paper
• A review of the worldwide prevalence of vitiligo in children/adolescents and adults

  2012cited by this paper
• Interleukin‐4 genetic variants correlate with its transcript and protein levels in patients with vitiligo

  2012cited by this paper
• Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference

  2012cited by this paper
• Inflammasomes in carcinogenesis and anticancer immune responses

  2012cited by this paper
• VNTR polymorphism of human IL1RN in Chinese Han and She ethnic populations

  2011cited by this paper
• Cytotoxic T‐lymphocyte‐associated antigen‐4 (CTLA‐4) in isolated vitiligo: a genotype‐phenotype correlation

  2011cited by this paper
• Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.

  2011cited by this paper
• Interleukin-1 (IL-1) Pathway

  2010cited by this paper
• Association between IL4 (-590), ACE (I)/(D), CCR5 (Delta32), CTLA4 (+49) and IL1-RN (VNTR in intron 2) gene polymorphisms and vitiligo.

  2009cited by this paper
• Association of catalase T/C exon 9 and glutathione peroxidase codon 200 polymorphisms in relation to their activities and oxidative stress with vitiligo susceptibility in Gujarat population.

  2007cited by this paper
• Pharmacogenetic of antirheumatic treatments: clinical implications

  2007cited by this paper
• Vitiligo: compendium of clinico-epidemiological features.

  2007cited by this paper
• Increased tumor necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with nonsegmental vitiligo.

  2006cited by this paper
• Increased tumor necrosis factor alpha (TNF‐α) and interleukin 1 alpha (IL1‐α) levels in the lesional skin of patients with nonsegmental vitiligo

  2006cited by this paper
• Vitiligo: Clinical profiles in Vadodara, Gujarat

  2006cited by this paper
• Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis

  2004cited by this paper
• Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families.

  2003cited by this paper
• Cytokines and autoimmunity

  2002cited by this paper
• Genetic control of IL‐1β bioactivity through differential regulation of the IL‐1 receptor antagonist

  2002cited by this paper
• Influence of interleukin-1 receptor antagonist gene polymorphism on disease.

  2002cited by this paper
• The balance between IL-1 and IL-1Ra in disease.

  2002cited by this paper
• Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases

  2002cited by this paper
• Interleukin-1 receptor antagonist as therapy for inflammatory disorders

  2001cited by this paper
• Polymorphisms in the IL‐1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies

  2000cited by this paper
• Systemic lupus erythematosus candidate genes in the Italian population: evidence for a significant association with interleukin-10.

  2000cited by this paper
• Biological role of interleukin 1 receptor antagonist isoforms

  2000cited by this paper
• Interleukin-1 Receptor Antagonist Expression in Human Endothelial Cells and Atherosclerosis

  2000cited by this paper
• Interleukin-1 Receptor Antagonist Expression in Human Endothelial Cells and Atherosclerosis

  2000cited by this paper
• Four New Members Expand the Interleukin-1 Superfamily*

  2000cited by this paper
• Influence of Polymorphism in the Genes for the Interleukin (IL)-1 Receptor Antagonist and IL-1β on Tuberculosis

  1999cited by this paper
• Interleukin-1 receptor antagonist gene therapy for arthritis.

  1999cited by this paper
• Interleukin-1 receptor antagonist: role in biology.

  1998cited by this paper
• Presence of the IL‐1RA Allele 2 (IL1RN*2) is Associated with Enhanced IL‐1β Production In Vitro

  1998cited by this paper
• Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment

  1996cited by this paper
• Cytokine production by normal human monocytes: inter‐subject variation and relationship to an IL‐1 receptor antagonist (IL‐1Ra) gene polymorphism

  1995cited by this paper
• The minigrafting test for vitiligo: detection of stable lesions for melanocyte transplantation.

  1995cited by this paper
• The minigrafting test for vitiligo: detection of stable lesions for melanocyte transplantation.

  1995cited by this paper
• Polymorphism in the IL-1 Receptor Antagonist Gene in Vitiligo

  1995cited by this paper
• Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist.

  1994cited by this paper
• Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus.

  1994cited by this paper
• Monokine Antagonism Is Reduced in Patients With IDDM

  1994cited by this paper
• The human interleukin-1 receptor antagonist (IL1RN) gene is located in the chromosome 2q14 region.

  1993cited by this paper
• Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat

  1993cited by this paper
• Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease.

  1992cited by this paper
• Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody

  1991cited by this paper
• Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor.

  1991cited by this paper

• Interleukin 1α and interleukin 18 in patients with vitiligo - Results of a case-control study.

  2023cites this paper
• Interleukin-1 receptor antagonist (IL-1RA) and interleukin-4 (IL-4) variable number of tandem repeat polymorphisms in schizophrenia and bipolar disorder: an association study in Turkish population

  2022cites this paper
• Elevated X-Box Binding Protein1 Splicing and Interleukin-17A Expression Are Associated With Active Generalized Vitiligo in Gujarat Population

  2022cites this paper
• Role of cytokines in multiple myeloma: IL-1RN and IL-4 VNTR polymorphisms.

  2022cites this paper
• The Immunogenetics of Vitiligo: An Approach Toward Revealing the Secret of Depigmentation.

  2022cites this paper
• V-set domain containing T-cell activation inhibitor-1 (VTCN1): A potential target for the treatment of autoimmune diseases.

  2022cites this paper
• Variations in TAP1 and PSMB9 Genes Involved in Antigen Processing and Presentation Increase the Risk of Vitiligo in the Saudi Community

  2021cites this paper
• A Concise Review on the Role of Endoplasmic Reticulum Stress in the Development of Autoimmunity in Vitiligo Pathogenesis

  2021cites this paper
• Interleukin-1 Receptor Antagonist (IL-1RN) Gene Variable Number Tandem Repeats (VNTR) Polymorphism Association in men Infertility in Erbil City /Kurdistan Iraq

  2021cites this paper
• Genetic polymorphism of interleukin-1 receptor antagonist in Type 1 diabetic children

  2021cites this paper
• Expression analysis of candidate genes in vitiligo patients & effect of oxidative stress on melanocytes

  2021cites this paper
• Investigation of the Role of Interleukin 6 in Vitiligo Pathogenesis

  2020cites this paper
• VitiVar: A locus specific database of vitiligo associated genes and variations

  2019cites this paper
• Interleukin 1 receptor antagonist gene variable number of tandem repeats polymorphism and cutaneous melanoma

  2019cites this paper